Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-24

Clinical Trial Update: A Study on the Preference of Risperidone Dosage Forms

View source ↗

Summary

Clinical trial sponsored by Shanghai Mental Health Center evaluating preferences for risperidone dosage forms across schizophrenia, bipolar disorder, autism spe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperidone (Risperdal) (Risperidone)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Schizophrenia, Bipolar Affective Disorder | Status: RECRUITING